Target intelligence / Profile preview

N-acetyl-L-cysteine (NAC) (NAC)

Target
NAC
Molecular classification
Amino acid derivative, Thiol compound, Antioxidant, Mucolytic, Other
01

Overview

N-acetylcysteine (NAC) is a derivative of the sulfur-containing amino acid L-cysteine and serves as a critical precursor for the synthesis of glutathione (GSH), the body's primary endogenous antioxidant (PubChem, CID 12035). While often categorized as a drug or dietary supplement rather than a classical therapeutic target, NAC is central to redox homeostasis and cellular detoxification (StatPearls, NBK537183). Its primary clinical roles include serving as the gold-standard antidote for acetaminophen overdose by replenishing hepatic GSH and acting as a mucolytic agent in respiratory diseases by cleaving disulfide bonds in mucins (Wikipedia, Acetylcysteine). Beyond these established uses, NAC is increasingly investigated for its ability to modulate glutamatergic signaling via the cystine-glutamate antiporter (System xc-) and its anti-inflammatory effects through the inhibition of NF-κB (PMC, PMC3044191). Its multifaceted mechanism of action makes it a versatile tool in treating conditions ranging from chronic bronchitis to neuropsychiatric disorders characterized by oxidative stress and glutamate dysregulation (PMC, PMC5241507).

Other names
AcetylcysteineN-acetylcysteineL-alpha-acetamido-beta-mercaptopropionic acidMercapturic acidMucomystAcetadoteParvolex
02

Mechanism of action

N-acetylcysteine acts as a prodrug for L-cysteine, which is the rate-limiting substrate for the synthesis of the antioxidant glutathione (GSH). It also possesses a free thiol group that directly scavenges reactive oxygen species and reduces disulfide bonds in mucoproteins, thereby decreasing mucus viscosity. Additionally, it modulates the cystine-glutamate antiporter (System xc-), increasing extracellular glutamate levels and influencing glutamatergic neurotransmission.

03

Biological functions

Antioxidant activityGlutathione synthesisMucolysisNeurotransmission modulationDetoxificationImmune responseApoptosisOther
04

Disease associations

InflammationNeurodegenerative diseaseInfectionCancerOther
05

Safety considerations

Anaphylactoid reactionsBronchospasmNausea and vomitingUnpleasant sulfurous odor
06

Interacting drugs

Acetaminophen

4 more in the full profile.

07

Biomarkers

Glutathione (GSH) levelsN-acetyl-p-benzoquinone imine (NAPQI) levelsAlanine aminotransferase (ALT)Malondialdehyde (MDA)

Beyond the preview

Go deeper on N-acetyl-L-cysteine (NAC) (NAC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acetyl-L-cysteine (NAC) (NAC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call